# Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.

> **NCT03739333** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **OTHER:** 11C-Methionine PET-MRI

## Key facts

- **NCT ID:** NCT03739333
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-26
- **Primary completion:** 2020-02-26
- **Final completion:** 2025-01-26
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739333, "Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03739333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*